Personal tools

MCL coexpression mm9:2943: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0001017!8.06e-29!73;UBERON:0001016!1.76e-27!75;UBERON:0004121!1.59e-26!95;UBERON:0000924!1.59e-26!95;UBERON:0006601!1.59e-26!95;UBERON:0000073!8.84e-25!54;UBERON:0001049!1.13e-23!52;UBERON:0005068!1.13e-23!52;UBERON:0006241!1.13e-23!52;UBERON:0007135!1.13e-23!52;UBERON:0002346!7.07e-23!64;UBERON:0003075!7.07e-23!64;UBERON:0007284!7.07e-23!64;UBERON:0000955!1.31e-22!47;UBERON:0006238!1.31e-22!47;UBERON:0002616!7.43e-22!46;UBERON:0010371!1.34e-20!73;UBERON:0003080!3.56e-19!40;UBERON:0002780!1.80e-18!39;UBERON:0001890!1.80e-18!39;UBERON:0006240!1.80e-18!39;UBERON:0003056!2.65e-18!49;UBERON:0002020!1.96e-17!34;UBERON:0003528!1.47e-16!29;UBERON:0002791!1.47e-16!29;UBERON:0001893!1.47e-16!29;UBERON:0010314!1.58e-16!92;UBERON:0000956!1.57e-12!21;UBERON:0001869!1.57e-12!21;UBERON:0000203!1.57e-12!21;UBERON:0002619!2.11e-10!17;UBERON:0000468!4.45e-10!333;UBERON:0004111!2.87e-08!122;UBERON:0002021!1.56e-07!10;UBERON:0000411!1.56e-07!10;UBERON:0001950!1.56e-07!10;UBERON:0000025!1.92e-07!114
|ontology_enrichment_uberon=UBERON:0001017!8.06e-29!73;UBERON:0001016!1.76e-27!75;UBERON:0004121!1.59e-26!95;UBERON:0000924!1.59e-26!95;UBERON:0006601!1.59e-26!95;UBERON:0000073!8.84e-25!54;UBERON:0001049!1.13e-23!52;UBERON:0005068!1.13e-23!52;UBERON:0006241!1.13e-23!52;UBERON:0007135!1.13e-23!52;UBERON:0002346!7.07e-23!64;UBERON:0003075!7.07e-23!64;UBERON:0007284!7.07e-23!64;UBERON:0000955!1.31e-22!47;UBERON:0006238!1.31e-22!47;UBERON:0002616!7.43e-22!46;UBERON:0010371!1.34e-20!73;UBERON:0003080!3.56e-19!40;UBERON:0002780!1.80e-18!39;UBERON:0001890!1.80e-18!39;UBERON:0006240!1.80e-18!39;UBERON:0003056!2.65e-18!49;UBERON:0002020!1.96e-17!34;UBERON:0003528!1.47e-16!29;UBERON:0002791!1.47e-16!29;UBERON:0001893!1.47e-16!29;UBERON:0010314!1.58e-16!92;UBERON:0000956!1.57e-12!21;UBERON:0001869!1.57e-12!21;UBERON:0000203!1.57e-12!21;UBERON:0002619!2.11e-10!17;UBERON:0000468!4.45e-10!333;UBERON:0004111!2.87e-08!122;UBERON:0002021!1.56e-07!10;UBERON:0000411!1.56e-07!10;UBERON:0001950!1.56e-07!10;UBERON:0000025!1.92e-07!114
|tfbs_overrepresentation_for_novel_motifs=0.752782,0.193418,0.722405,0.801166,0.587814,0.81763,0.919454,0.467321,0.479531,0.235304,0.870507,0.906098,0.467629,0.933025,0.608226,0,1.14208,0.578045,0.448066,0.328717,0.679146,0.756749,0.932027,0.585919,0.731217,0.963352,0.437236,0.841386,0.64294,0.380786,0.825437,1.24901,0.575271,0.411696,0.608816,6.04797,1.38481,0.902078,0.536514,2.16143,0.582863,0.831295,0.261619,0.610669,0.474221,0.788421,1.05665,0.859154,0.235354,0.646474,1.12346,0.99279,0.371606,1.3966,1.41464,0.940919,0.657156,0.891887,0.425455,0.938668,1.22795,1.00308,0.494668,1.11142,0.953187,1.15459,1.55483,1.90983,1.22303,1.7608,0.700291,0.474956,1.41919,1.44925,1.882,1.03818,0.411601,1.04436,1.20986,0.684144,0.476502,1.16055,1.00151,0.459035,1.32978,0.181575,0.195254,0.380977,1.06194,2.07346,1.62608,1.33496,1.26245,0.595071,1.31639,0.509215,0.464141,1.26539,1.05692,0.352122,0.563856,1.24872,1.37854,1.12409,1.12297,0.830796,1.18646,0.854628,4.02421,0.681267,0.744607,1.38039,0.685481,0.876299,1.63327,0.580657,1.1471,0.805461,1.14346,0.559153,1.45481,1.08896,0.965352,1.04338,1.68841,1.21376,0.928483,1.25534,1.55328,0.598722,1.36093,0.792832,1.52297,0.955954,1.65529,0.751419,0.762499,0.832891,1.60513,2.44352,2.04137,1.55966,0.978551,1.26,1.11604,0.831808,1.06002,2.40374,0.765221,2.45536,0.38417,4.69532,1.39822,1.28513,0.954936,1.48249,0.993889,0.622823,0.749933,0.762177,1.61484,1.32889,1.21423,0.741984,1.11251,0.94678,0.562367,0.904334,0.421338
}}
}}

Revision as of 22:10, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr14:76814539..76814600,+p2@Tsc22d1
Mm9::chr14:76814601..76814630,+p5@Tsc22d1
Mm9::chr17:26206420..26206495,-p1@Rab11fip3


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
central nervous system8.06e-2973
nervous system1.76e-2775
ectoderm-derived structure1.59e-2695
ectoderm1.59e-2695
presumptive ectoderm1.59e-2695
regional part of nervous system8.84e-2554
neural tube1.13e-2352
neural rod1.13e-2352
future spinal cord1.13e-2352
neural keel1.13e-2352
neurectoderm7.07e-2364
neural plate7.07e-2364
presumptive neural plate7.07e-2364
brain1.31e-2247
future brain1.31e-2247
regional part of brain7.43e-2246
ecto-epithelium1.34e-2073
anterior neural tube3.56e-1940
regional part of forebrain1.80e-1839
forebrain1.80e-1839
future forebrain1.80e-1839
pre-chordal neural plate2.65e-1849
gray matter1.96e-1734
brain grey matter1.47e-1629
regional part of telencephalon1.47e-1629
telencephalon1.47e-1629
structure with developmental contribution from neural crest1.58e-1692
cerebral cortex1.57e-1221
cerebral hemisphere1.57e-1221
pallium1.57e-1221
regional part of cerebral cortex2.11e-1017
multi-cellular organism4.45e-10333
anatomical conduit2.87e-08122
occipital lobe1.56e-0710
visual cortex1.56e-0710
neocortex1.56e-0710
tube1.92e-07114


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}